Beta-blocker initiation and adherence after hospitalization for acute myocardial infarction

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 18, Issue 3, 2011, Pages 438-445

  Maio, Vittorio ^a   Marino, Massimiliano ^b   Robeson, Mary ^c   Gagne, Joshua J ^d,e  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Regional Health Care Agency   (Italy)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Acute myocardial infarction; Adherence; Beta blockers; Pharmacoepidemiology; Secondary prevention; Utilization

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE; PROPRANOLOL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART CATHETERIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POST AMI BETA BLOCKER INITIATION; PRESCRIPTION; PRIORITY JOURNAL; THERAPY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79959214530     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/1741826710389401     Document Type: Article

References (34)

1. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F and Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327: 248-254.
2. Phillips KA, Shlipak MG, Coxson P, Heidenreich PA, Hunink MG, Goldman PA, et al. Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA 2000; 284: 2748-2754.
3. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999; 100: 1016-1030. (Pubitemid 29407188)
4. López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, et al. Task force on betablockers of the European Society of Cardiology. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 2004; 25: 1341-1362.
5. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003; 10: S1-S10.
6. Rasmussen JN, Chong A and Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007; 297: 177-186. (Pubitemid 46089734)
7. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A and Marciniak TA. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998; 280: 623-629.
8. Wei L, Flynn R, Murray GD and MacDonald TM. Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment? Pharmacoepidemiol Drug Saf 2004; 13: 761-766.
9. Schneeweiss S, Patrick AR, Maclure M, Dormuth CR and Glynn RJ. Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction. Am J Manag Care 2007; 13: 445-452. (Pubitemid 47301271)
10. Rochon PA, Anderson GM, Tu JV, Clark JP, Gurwitz JH, Szalai JP, et al. Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario. CMAJ 1999; 161: 1403-1408.
11. Choudhtry NK and Winkelmayer WC. Medication adherence after myocardial infarction: a long way left to go. J Gen Inten Med 2008; 23: 216-218.
12. Choudhry NK, Setoguchi S, Levin R, Winkelmayer WC and Shrank WH. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf 2008; 17: 1189-1196.
13. Avanzini F, Zuanetti G, Latini R, Colombo F, Santoro E, Maggioni AP, et al. Use of beta-blocking agents in secondary prevention after myocardial infarction: A case for evidence-based medicine? GISSI experience, 1984-1993. The Gruppo Italiano di Studio sulla Sopravvivenza nell'Infarto Miocardico (GISSI) Investigators. Eur Heart J 1997; 18: 1447-1456.
14. Maio V and Gagne JJ. Impact of ALLHAT publication on antihypertensive prescribing patterns in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 2010; 35: 55-61.
15. Gagne JJ, Maio V, Berghella V, Louis DZ and Gonnella JS. Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy. Eur J Clin Pharmacol 2008; 64: 1125-1132.
16. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J and Solomon DH. The accuracy of Medicare claims-based diagnosis of acute myocardial infarction. Am Heart J 2004; 148: 99-104.
17. Iezzoni LI, Burnside S, Sickles L, Moskowitz MA, Sawitz E and Levine PA. Coding of acute myocardial infarction. Clinical and policy implications. Ann Intern Med 1988; 109: 745-751.
18. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G and Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997; 277: 115-121. (Pubitemid 27030178)
19. Maio V, Yuen E, Rabinowitz C, Louis D, Jimbo M, Donatini A, et al. Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy. J Health Serv Res Policy 2005; 10: 232-238. (Pubitemid 41540275)
20. Maio V, Yuen EJ, Novielli K, Smith KD and Louis DZ. Potentially inappropriate medication prescribing for elderly outpatients in Emilia Romagna, Italy: a population-based cohort study. Drugs Aging 2006; 23: 915-924. (Pubitemid 44788142)
21. Gagne JJ, Maio V and Rabinowitz C. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 2008; 33: 141-151. (Pubitemid 351341403)
22. Schneeweiss S, Wang PS, Avorn J, Maclure M, Levin R and Glynn RJ. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. J Gen Intern Med 2004; 19: 444-450. (Pubitemid 38638905)
23. Choudhry NK, Shrank WH, Levin RL, Lee JL, Jan SA, Brookhart MA, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care 2009; 15: 457-464.
24. Andrade SE, Kahler KH, Frech F and Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006; 15: 565-574. discussion 575-577.
25. Atella V, Peracchi F, Depalo D and Rossetti C. Drug compliance, co-payment and health outcomes: Evidence from a panel of Italian patients. Health Econ 2006; 15: 875-892. (Pubitemid 44463365)
26. ATC/DDD Index, WHO Collaborating Centre for Drug Statistics Methodology, http://www.whocc.no/atcddd (2006, consulted October 2007).
27. Lamb DA, Eurich DT, McAlister FA, Tsuyuki RT, Semchuk, Wilson TW, et al. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003. Circ Cardiovasc Qual Outcomes 2009; 2: 228-235.
28. Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M and Klaukka T. Use of secondary preventive medications after the first attack of acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 2007; 14: 386-391. (Pubitemid 46945561)
29. Jackevicius CA, Li P and Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 2008; 117: 1028-1036.
30. Jackevicius CA, Paterson JM and Naglie G. Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients. Pharmacoepidemiol Drug Saf 2007; 16: 207-215. (Pubitemid 46291172)
31. Gottlieb SS, McCarter RJ and Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998; 339: 489-497. (Pubitemid 28384881)
32. Chandra A and Staiger D. Testing a Roy model with productivity spillovers: evidence from the treatment of heart attacks. NBER Working Paper No. 10811, September 2004.
33. Stukel TA, Lucas FL and Wennberg DE. Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare Patients with acute myocardial infarction. JAMA 2005; 293: 1329-1337. (Pubitemid 40381485)
34. Nobilio L and Ugolini C. Selective referrals in a 'hub and spoke' institutional setting: the case of coronary angioplasty procedures. Health Policy 2003; 63: 95-107.